Novartis
NVS
NVS
1,171 hedge funds and large institutions have $24.4B invested in Novartis in 2019 Q4 according to their latest regulatory filings, with 156 funds opening new positions, 412 increasing their positions, 387 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,171
Holders Change
+82
Holders Change %
+7.53%
% of All Funds
23.12%
Holding in Top 10
23
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+64.29%
% of All Funds
0.45%
New
156
Increased
412
Reduced
387
Closed
55
Calls
$200M
Puts
$129M
Net Calls
+$71M
Net Calls Change
+$62.6M
Top Buyers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$299M |
| 2 |
Jennison Associates
New York
|
+$238M |
| 3 |
BlackRock
New York
|
+$220M |
| 4 |
Aristotle Capital Management
Los Angeles,
California
|
+$216M |
| 5 |
Renaissance Technologies
New York
|
+$132M |
